A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers.

MLA

Mahar, Kelly M., et al. “A Single- and Multiple-Dose Study to Investigate the Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers.” Clinical Pharmacology in Drug Development, vol. 4, no. 6, Nov. 2015, pp. 418–26. EBSCOhost, https://doi.org/10.1002/cpdd.210.

APA

Mahar, K. M., Stier, B., Fries, M., & McCallum, S. W. (2015). A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers. Clinical Pharmacology in Drug Development, 4(6), 418–426. https://doi.org/10.1002/cpdd.210

Chicago

Mahar, Kelly M, Brendt Stier, Michael Fries, and Stewart W McCallum. 2015. “A Single- and Multiple-Dose Study to Investigate the Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers.” Clinical Pharmacology in Drug Development 4 (6): 418–26. doi:10.1002/cpdd.210.